SPDR S&P Biotech ETF (NYSEARCA:XBI) Shares Acquired by Kovack Advisors Inc.

Kovack Advisors Inc. increased its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 35.1% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 6,146 shares of the exchange traded fund’s stock after acquiring an additional 1,597 shares during the period. Kovack Advisors Inc.’s holdings in SPDR S&P Biotech ETF were worth $553,000 as of its most recent SEC filing.

Other hedge funds have also modified their holdings of the company. Golden State Wealth Management LLC acquired a new stake in shares of SPDR S&P Biotech ETF in the fourth quarter worth approximately $29,000. Avior Wealth Management LLC lifted its position in SPDR S&P Biotech ETF by 393.6% during the fourth quarter. Avior Wealth Management LLC now owns 385 shares of the exchange traded fund’s stock valued at $35,000 after buying an additional 307 shares in the last quarter. Tidemark LLC lifted its position in SPDR S&P Biotech ETF by 101.5% during the third quarter. Tidemark LLC now owns 395 shares of the exchange traded fund’s stock valued at $39,000 after buying an additional 199 shares in the last quarter. Quintet Private Bank Europe S.A. acquired a new position in SPDR S&P Biotech ETF during the third quarter valued at approximately $40,000. Finally, Bank of Jackson Hole Trust acquired a new position in SPDR S&P Biotech ETF during the fourth quarter valued at approximately $43,000.

SPDR S&P Biotech ETF Stock Up 1.8 %

Shares of XBI stock opened at $88.71 on Friday. The stock has a market cap of $5.85 billion, a price-to-earnings ratio of 11.47 and a beta of 0.93. SPDR S&P Biotech ETF has a fifty-two week low of $81.14 and a fifty-two week high of $105.47. The firm’s 50 day moving average price is $91.00 and its two-hundred day moving average price is $95.76.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.